Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06077422 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

StatusEnrolling by Invitation
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 11, 2025 to Jan 11, 2027v5 Show 4 more changesShow less
    • Trial status: Recruiting to Enrolling by Invitation
    • Enrollment target: 120 to 150
    • Study completion date: Apr 5, 2025 to Apr 5, 2027
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary completion date: Jan 2, 2025 to Jan 11, 2025
    • Start date changed from estimate of Jan 2, 2024 to Jan 11, 2024
    v4
  3. Primary endpoints: 2 to 1
    • Eligibility criteria expanded, about 43 words
    • Secondary endpoints: 6 to 7
    • Study description revised
    v3
  4. Secondary endpoints: 5 to 6
    • Study description expanded, about 7 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot study is to describe and compare Ultrasound-Guided Erector Spinae Plane (ESP) Blocks using Exparel® (bupivacaine liposome injectable suspension) to Marcaine® (bupivacaine hydrochloride) for pain management and outcomes after cardiac surgeries.
Trial Details
NCT Number NCT06077422
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: Pacira Pharmaceuticals, Inc
Conditions
(from sponsor)		 Pain, Postoperative, Opioid Use, Perioperative Complication, Heart Diseases
Related terms Heart Diseases, Pain, Postoperative Pain
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov